Editas Medicine Current Deferred Revenue (Quarterly) Trends

Editas Medicine, Inc. (EDIT)

2.10 -0.07 (-3.23%) USD | NASDAQ | Dec 29, 16:00

2.10 0.00 (0.00%) Pre-Market: 09:06

View Current Deferred Revenue (Quarterly) for EDIT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	Upgrade
Arcutis Biotherapeutics, Inc.	--
Daré Bioscience, Inc.	Upgrade
Cogent Biosciences, Inc.	--
Janux Therapeutics, Inc.	--